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Increased neuronal spontaneous firing rates have been observed throughout the central
auditory system after trauma to the cochlea and this hyperactivity is believed to be associ-
ated with the phantom perception of tinnitus. Previously, we have shown in an animal model
of hearing loss, that an acute injection with furosemide can significantly decrease hyper-
activity after cochlear trauma and eliminate behavioral evidence of tinnitus of early onset.
However, furosemide also has the potential to affect cochlear thresholds. In this paper, we
measured the effects of a chronic (daily injections for 7 days) furosemide treatment on the
spontaneous firing rate of inferior colliculus neurons and on cochlear thresholds in order
to establish whether a beneficial effect on hyperactivity can be obtained without causing
additional hearing loss. Guinea pigs were exposed to a 10–kHz, 124 dB, 2 h acoustic trauma,
and after 5 days of recovery, were given daily i.p. injections of 80 mg/kg furosemide or an
equivalent amount of saline. The activity of single IC neurons was recorded 24 h following
the last injection. The furosemide treatment had no effect on cochlear thresholds com-
pared to saline injections but did result in significant reductions in spontaneous firing rates
recorded in inferior colliculus. These results that suggest a long-term beneficial effect of
furosemide on hyperactivity after cochlear trauma may be achievable without detrimental
effects on hearing, which is important when considering therapeutic potential.
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INTRODUCTION
Tinnitus, a phantom auditory perception, is generally thought to
be the results of abnormal activity along the central auditory path-
ways that is often triggered by damage to the auditory receptor,
the cochlea (1). One form of abnormal activity observed after
cochlear damage is increased spontaneous activity (hyperactivity),
which has been shown to be present in cochlear nucleus, inferior
colliculus, and auditory cortex (2–6).
Hyperactivity is thought to be the result of an increased central
gain following peripheral denervation (7) and available evidence
suggests that it is, at least at an early stage, still dependent on
the remaining spontaneous drive from cochlear afferents. This has
been demonstrated in guinea pigs in which central hyperactivity
in inferior colliculus can be eliminated by silencing the cochlea
during an early period following acoustic trauma (5), though this
effect could not be found at later time points following trauma (8).
If indeed hyperactivity plays a role in the generation of tin-
nitus, these data suggest that tinnitus of recent onset may be
sensitive to treatments affecting the activity of the auditory nerve.
This was confirmed in a recent paper in which it was reported
that an acute injection with furosemide, at a dose that caused a
reduction of the spontaneous activity of the auditory nerve and
a reduction of central hyperactivity, also caused an elimination
of the early behavioral signs of tinnitus in guinea pigs exposed
to cochlear trauma (9). These data, obtained in an animal model,
could provide a possible explanation for the fact that VIII nerve
transection can decrease tinnitus perception in a proportion of
patients (10) and for the fact that furosemide has been shown to
suppress the perception of tinnitus in some patients (11–13).
The effects of acute furosemide administration on hyperactiv-
ity and tinnitus suggest a therapeutic potential for furosemide in
treating early onset tinnitus, although, it is likely that chronic treat-
ment would be needed to achieve ongoing suppression. However, it
is also known that furosemide can affect cochlear thresholds, caus-
ing hearing loss. Therefore, the present study investigated whether
chronic administration of furosemide could decrease hyperactivity
without deleterious effects on cochlear thresholds. The effects of a
chronic (administered daily for 7 days) furosemide treatment on
central hyperactivity and cochlear thresholds were studied in our
guinea pig model of hearing loss and hyperactivity after acoustic
trauma.
MATERIALS AND METHODS
ANIMALS
Nine adult pigmented guinea pigs of either sex were used. Animals
weighed between 290 and 500 g at the time of acoustic trauma. The
experimental protocols conformed to the Code of Practice of the
National Health and Medical Research Council of Australia, and
were approved by the Animal Ethics Committee of The University
of Western Australia.
RECOVERY SURGERY FOR ACOUSTIC TRAUMA
Animals received a sub-cutaneous injection of 0.1 ml atropine sul-
fate (0.6 mg/ml) as pre-medication, followed by an intraperitoneal
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injection of diazepam (5 mg/kg) and an intramuscular injection of
Hypnorm (0.315 mg/ml fentanyl citrate and 10 mg/ml fluanisone;
1 ml/kg). The surgery commenced when there was an absence
of the foot withdrawal reflex indicating deep anesthesia. Animals
were placed on a heating pad in a sound proof room and posi-
tioned in hollow ear bars. Eyes were protected from drying out by
application of an eye-gel. A small incision was made behind the left
ear and the bulla was opened to visualize the cochlea in order to
place an insulated silver wire electrode on the cochlear round win-
dow. This enabled recording a compound action potential (CAP)
audiogram (14) for the frequency range 4–24 kHz in order to assess
the animals’ cochlear sensitivity.
All sound stimuli were presented in a closed sound system
through a 1/2′′ condenser microphone driven in reverse as a
speaker (Bruel and Kjaer, type 4134). Pure tone stimuli were
synthesized by a computer equipped with a DIGI 96 soundcard
connected to an analog/digital interface (ADI-9 DS, RME Intelli-
gent Audio Solution). Sample rate was 96 kHz. The interface was
driven by a custom-made computer program (Neurosound, MI
Lloyd), which was also used to collect single neuron data during the
final experiments. CAP signals were amplified, filtered (100–3 kHz
bandpass) and recorded with a second data acquisition system
(Powerlab 4SP, AD Instruments).
When cochlear sensitivity was within the normal range (14),
animals received a unilateral acoustic trauma (2 h continuous pure
tone of 10 kHz at 124 dB SPL) in the left cochlea while the con-
tralateral ear was blocked with plasticine. Immediately after the
acoustic trauma the CAP audiogram was measured again and the
incision was sutured. Animals were then monitored hourly until
full recovery from anesthesia after which they were returned to the
animal housing facility.
TREATMENT
Animals were allowed to recover for 5 days after acoustic trauma
and were then assigned randomly to either a furosemide group
(n= 5) or a saline control group (n= 4). Intraperitoneal injections
of 80 mg/kg furosemide (or an equivalent volume of saline) were
administered daily for 7 days (day 5 till day 11 post-trauma). Sin-
gle neuron recordings in CNIC and CAP threshold measurements
(as described above) were taken 1 day after the final furosemide or
saline treatment (day 12 post-trauma).
SURGERY FOR FINAL EXPERIMENTS
Animals received a sub-cutaneous injection with 0.1 ml atropine
followed by an intraperitoneal injection of Nembutal (pentobarbi-
tone sodium, 30 mg/kg) and a 0.15 ml intramuscular injection of
Hypnorm. Anesthesia was maintained with full Hypnorm doses
every hour and half doses of Nembutal every 2 h. When deep
anesthesia was obtained as determined by the absence of the foot
withdrawal reflex, the areas of incision were shaved and animals
were placed on a heating blanket in a sound proof room and arti-
ficially ventilated on carbogen (95% O2 and 5% CO2). The elec-
trocardiogram was continuously monitored and heart rate never
increased over pre-paralysis levels at any stage of the experiments.
After the animals were mounted in hollow ear bars, the left and
right cochleae were exposed and CAP audiograms were recorded
on both sides with a silver wire placed on the round window as
described for the recovery procedures. Paralysis was then induced
with 0.1 ml pancuronium bromide (2 mg/ml intramuscularly).
For extracellular single neuron recordings in the central nucleus
of the inferior colliculus (CNIC) a small craniotomy overlying the
visual cortex was performed and a glass-insulated tungsten micro-
electrode (15) was advanced using a stepping motor microdrive
along the dorso-ventral axis through the cortex into the CNIC con-
tralateral to the cochlea subjected previously to acoustic trauma.
The craniotomy was covered with 5% agar in saline to improve
mechanical stability. Electrode placement in the CNIC (about 2.5–
3 mm ventral to the cortical surface) was indicated by the presence
of strong sound-driven activity with a short latency and a system-
atic progression from low to high characteristic frequencies (CF)
with increasing depth. We have previously confirmed histologi-
cally that these response properties correlate with location of the
electrode in the CNIC (16). When a single unit was isolated its CF
and threshold at CF were determined audio-visually and depth
from the cortical surface was recorded. Spontaneous firing rate
was measured for a period of 10 s.
DATA ANALYSIS
Hearing loss can result in changes to the tuning curves of neu-
rons, so that determination of CF based on the lowest threshold
of tuning curves in the damaged region can be erroneous (17). We
therefore calculated a nominal CF for all neurons collected in this
study based on the recorded unit’s electrode depth into the CNIC
(from cortical surface) during post-experimental analysis [See also
Ref. (5, 16)]. The highly structured tonotopic map of the IC allows
for CF to be estimated using depth measurements. In each animal,
we constructed a plot of audio-visually determined CFs from all
neurons in regions that were unaffected by the acoustic trauma
against their depth into the CNIC. A second-order polynomial
function was then fitted to these plots and the formula of the
fitted curve was then used to transform depth into nominal CF.
Nominal CF will be used in the remainder of the manuscript.
To identify statistically significant differences in spontaneous
firing rates between chronic intraperitoneal injections with
furosemide or saline, the Mann–Whitney test was used when
comparing all neurons in each group with each other and the
Kruskall–Wallis test and Dunn’s multiple comparison post-test
when comparing the neurons sorted according to CF range. Sta-
tistical analysis of CAP threshold changes at each frequency was
performed using a one-way ANOVA.
RESULTS
EFFECTS OF CHRONIC FUROSEMIDE ON PERIPHERAL THRESHOLDS
Figure 1A shows the average CAP threshold loss in the exposed ear
of both saline and furosemide treated animals on day 12 after the
acoustic trauma. Both groups of animals showed CAP threshold
losses at frequencies >10 kHz in line with data published previ-
ously using the same animal model (5, 16). Furthermore, there
were no statistically significant differences between the groups at
any frequency, including the lower frequencies that were unaf-
fected by the acoustic trauma. These results show that the chronic
administration of furosemide did not have additional lasting
effects on the peripheral thresholds.
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FIGURE 1 | (A) Mean threshold loss (mean±SEM) at multiple
frequencies after recovery from acoustic trauma (day 12) from animals
that were treated with saline (open circles, n=4) of furosemide (black
circles, n= 5). (B) Histogram showing median spontaneous firing rate in
CNIC in saline (362 neurons from four animals, white bar) and
furosemide treated groups (398 neurons from five animals, black bar)
12 days after acoustic trauma. Median shown with 25 and 75%
percentile. (C) Histogram showing median spontaneous firing rate of
CNIC neurons in high and low frequency regions in saline treated
animals (white bars) and furosemide treated animals (black bars) on day
12 after acoustic trauma. Bars show median with 25 and 75% percentile
**p<0.01; ****p< 0.0001.
EFFECTS OF CHRONIC FUROSEMIDE ON CENTRAL NEURAL ACTIVITY
In total, data were obtained from 362 neurons in the CNIC of saline
treated animals and 398 neurons from the CNIC of furosemide
treated animals. Spontaneous firing rates in saline treated animals
varied between 0 and 77.6 spikes/s with a mean spontaneous fir-
ing rate of 6.5± 0.65 (median 1.5) spikes/s and in furosemide
treated animals between 0 and 52.5 spikes/s with an average rate
of 3.45± 0.36 spikes/s (median 0.4) (Figure 1B). The spontaneous
firing rate in furosemide treated animals was significantly reduced
compared to saline treated animals (p< 0.0001).
In order to investigate whether furosemide was equally affecting
the spontaneous firing rate of all neurons throughout the tono-
topic map of the IC, neurons were also sorted according to CF.
The spontaneous firing rates in saline and furosemide treated
animals were compared for neurons with a CF< 12 kHz (non-
hearing loss region) and a CF> 12 kHz (hearing loss region).
Results from this analysis are shown in Figure 1C. In agree-
ment with previously published data that showed a strong cor-
relation between the frequency regions in the CNIC show-
ing increased spontaneous firing and the peripheral frequency
regions of hearing loss (16), Figure 1C shows statistically ele-
vated levels of spontaneous firing rate in the CF region >12 kHz
compared to the CF region <12 kHz in saline treated animals
(p< 0.0001). Statistical analysis showed a significant decrease after
furosemide in both CF groups (p< 0.01 for CFs <12 kHz and
p< 0.0001 for CFs>12 kHz). The largest effect of furosemide was
seen in the frequency region that showed the most prominent
hyperactivity.
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DISCUSSION
The results presented in this paper show that 1 day after a 7-day
course of furosemide central hyperactivity in inferior colliculus is
reduced without effects on peripheral auditory thresholds. These
results are in agreement with the results of single acute furosemide
injections, which also result in suppression of hyperactivity and
they show that chronic administration can have beneficial effects
centrally without causing further hearing loss. Further experi-
ments are required to investigate the duration of the benefit from
repeated administration and whether this is accompanied by a
concomitant reduction of tinnitus.
Importantly, chronic administration of furosemide did not
affect the magnitude of the hearing loss following acoustic trauma
compared to saline injections. This indicates that furosemide did
not have long-lasting effects on cochlear thresholds, even though
studies do suggest a possible short-term effect on sound-evoked
responses in the cochlea (18–20). Furosemide, a loop-diuretic, is
known to decrease the endocochlear potential in the cochlea via
an effect on the Na-K-2Cl co-transporter in the stria vascularis
(21). This can lead to temporary decreases in the spontaneous fir-
ing of the auditory nerve (20, 22), increases in the thresholds of
single auditory nerve fibers, and a reduction in the CAP ampli-
tude of the auditory nerve (18–20). However, the latter studies did
report that the effects of the furosemide doses used (100 mg/kg
in chinchilla, or i.v. infusion in cats at 10 mg/ml) were reversible
and significantly attenuated within an hour of treatment (18–20).
Furthermore, Sewell (19) also showed that the spontaneous firing
of primary afferent neurons was more susceptible to furosemide
effects than was auditory sensitivity. This is also in agreement
with our previous study showing initial increases in neuronal
thresholds in IC after intracochlear perfusion of furosemide,which
recovered fully after 1 h (9). The dose of furosemide used in this
study may therefore have decreased the sound-evoked activity
for a brief period after the injection, but there was no long-
lasting effect on peripheral thresholds as the CAP audiogram data
indicate.
Overall spontaneous firing rates were significantly reduced after
the chronic treatment with furosemide as compared to saline.
This is the same effect as observed after acute administration of
furosemide at the same dosage (9). In addition, this reduction is
most striking in the tonotopic regions >12 kHz, although it was
significantly suppressed in the frequency region<12 kHz as well. It
is noteworthy that this effect of furosemide was seen 24 h after the
last injection, whereas our previous study investigated effects only
immediately (within 4 h) after a single acute injection. The hyper-
activity is most pronounced in the frequency region >12 kHz,
which confirms earlier observations that there is a strong corre-
lation between the frequency regions showing hyperactivity and
the frequency extent of hearing loss (2, 16, 23, 24). The reduc-
tion in hyperactivity looks similar to that described previously
following complete cochlear ablation, cochlear cooling, and acute
administration of furosemide (5, 9), providing further evidence
that hyperactivity can be modulated by manipulations of auditory
nerve activity.
What is the cause of the reduction in spontaneous firing rates in
IC? Firstly, the level of hyperactivity is known to be affected by the
magnitude of hearing loss (16); however, no difference in hearing
loss was apparent between the saline and furosemide treated ani-
mals. In addition, since furosemide is thought to increase cochlear
thresholds (18–20), it would be expected to enhance the hearing
loss and thereby increasing the central spontaneous firing rates.
Secondly, the reduction in hyperactivity could be a direct result of
the reduced spontaneous activity in the auditory nerve caused by
furosemide nerve (9, 20, 22). As we have shown previously, the dose
of furosemide used in this study acutely decreases the spontaneous
firing rate in the cochlear nerve and also reduces the hyperactivity
in the IC (9). The 7-day course of furosemide may have caused a
long-term decrease of the auditory nerve spontaneous firing rate
without affecting the thresholds, which is very well possible since
the spontaneous firing rate is more sensitive to suppression of the
endocochlear potential than cochlear thresholds (22).
In view of the fact of our previous study showing that acute
administration of furosemide lowers the hyperactivity in IC and
eliminates the behavioral signs of tinnitus (9), the present results
suggest that chronic furosemide may have longer-lasting beneficial
effects on tinnitus and can be administered without detrimental
effects on hearing thresholds. This is an important observation
when considering furosemide as a treatment for early onset tinni-
tus. However, we do note that in the time window of the present
study animals are unlikely to have developed tinnitus yet since
we observed this between 4 and 6 weeks after cochlear trauma (9,
24). It is therefore necessary to investigate the effect of chronic
furosemide at later time points as well and establish whether it
is accompanied by a longer-lasting effect on tinnitus. Finally, it
is also of interest to research whether an early reduction of the
hyperactivity could prevent the establishment of behavioral tin-
nitus, which would further support a role for the hyperactivity in
the generation of tinnitus.
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